Syndax Pharmaceuticals (SNDX) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.07
-0.98
-0.89
-0.8

Details

Expected EPS
-1.069584
Actual EPS
-0.98
Surprise EPS
0.09
Surprise Percent
+8.38%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -0.98 per share for Q4 2024.

0 Comments

Share your thoughts